Use of NTCP metrics to identify unbalanced levels of dose trade‐off between left lung and heart in lung cancer radiotherapy
Journal of Applied Clinical Medical Physics · 2025
DOI: 10.1002/acm2.70207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Georgios Komisopoulos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Medical School, University of Thessaly, Larissa, Greece. Hauptthemen laut MEDLINE: Radiotherapy Planning, Computer-Assisted, Organs at Risk, Lung Neoplasms, Heart. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The aim of this study is to determine the optimal level of dose trade‐off between left lung and heart during plan optimization in lung cancer radiotherapy, and also to examine the impact of planning target volume (PTV) size in reducing the overall risk of toxicity of lung and heart.
Methods
This work includes 20 left‐sided lung cancer patients and for each of them two VMAT plans (dosimetrically and radiobiologically optimized) were developed. In all the plans, a dose of 70 Gy in 35 fractions was prescribed to PTV. Each plan was evaluated in terms of PTV coverage, mean lung dose, lung‐V 20 , mean heart dose, and heart‐V 5 . The normal tissue control probability (NTCP) values of radiation pneumonitis and heart valve dysfunction were calculated using the Relative Seriality model.
Results
The patients with PTV < 300 cm 3 had a left lung NTCP of 70.7 ± 14.6% and a heart NTCP of 11.5 ± 5.5%, whereas for the patients with PTV > 300 cm 3 , the corresponding NTCP values were 86.0 ± 9.5% for left lung and 13.7 ± 4.9% for heart, respectively. After the NTCP‐based optimization, for the patients with PTV < 300 cm 3 , the corresponding lung NTCP values had a decrease of 12.8% and the heart NTCP values had an increase of 2.7%, whereas for the patients with PTV > 300 cm 3 , the lung NTCP values had a decrease of 6.5% and the heart NTCP values had an increase of 3.9%.
Conclusion
Our results indicate that there is a systematic unbalance in dose trade‐off between left lung and heart, which varies based on the PTV size. NTCP metrics were found useful in identifying this issue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics, Medical School, University of Thessaly, Larissa, Greece.
- Department of Radiation Oncology, University of North Carolina at Chapel Hill, North Carolina, USA.
- Department of Radiation Oncology, IASO Thessaly Medical Center, Larissa, Greece.
- Department of Medical Physics, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
ORCID-Profile: Panayiotis Mavroidis
Zitieren
APA
Komisopoulos, G., Mavroidis, P., Simopoulou, F., Kyrgias, G., Pant, K., Roussakis, Y., & Theodorou, K. (2025). Use of NTCP metrics to identify unbalanced levels of dose trade‐off between left lung and heart in lung cancer radiotherapy. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70207
Vancouver
Komisopoulos G, Mavroidis P, Simopoulou F, Kyrgias G, Pant K, Roussakis Y, et al. Use of NTCP metrics to identify unbalanced levels of dose trade‐off between left lung and heart in lung cancer radiotherapy. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70207
BibTeX
@article{Komisopoulos2025,
author = {Komisopoulos, Georgios and Mavroidis, Panayiotis and Simopoulou, Fotini and Kyrgias, George and Pant, Kiran and Roussakis, Yiannis and Theodorou, Kyriaki},
title = {Use of NTCP metrics to identify unbalanced levels of dose trade‐off between left lung and heart in lung cancer radiotherapy},
journal = {Journal of Applied Clinical Medical Physics},
year = {2025},
doi = {10.1002/acm2.70207}
}
EUVIMED